Bausch & Lomb Corp (BLCO)
1 Item 5.02 filing since 2026-10-13 · 1 with an open seat · roles: CEO. NYSE. Ophthalmic Goods. State: A6.
| Score | Filed | Event | Role | Person | Seat | Summary |
|---|---|---|---|---|---|---|
| 95 | 2026-10-13 | Departure | CEO | subscribers | Open | Bausch & Lomb Corp (BLCO): CEO Brent Saunders mutual agreement; interim named |
Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works